LYNBROOK, N.Y., July 2, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S., today announced that BioSpecifics' President, Tom Wegman, will present a corporate overview at the 8th Annual JMP Securities Healthcare Conference at 4:00 p.m. EDT on Wednesday, July 10, 2013 in New York, NY.
The live webcast of this presentation can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website at www.biospecifics.com or at the link http://wsw.com/webcast/jmp21/bstc/.
About BioSpecifics Technologies Corp.
BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date. Injectable collagenase is marketed as XIAFLEX® in the U.S. for the treatment of adult Dupuytren's contracture patients with a palpable cord in the palm by BioSpecifics' partner, Auxilium Pharmaceuticals, Inc., and is approved for Dupuytren's contracture in the EU and Canada. XIAFLEX is also in clinical development for the treatment of several additional promising indications. The U.S. Food & Drug Administration has accepted for filing Auxilium's supplemental Biologics License Application for XIAFLEX for the potential treatment of Peyronie's disease. The FDA is expected to take action on the application by September 6, 2013, and, if approved, XIAFLEX will be the first and only biologic treatment indicated for Peyronie's disease. Auxilium is also testing XIAFLEX for frozen shoulder syndrome (adhesive capsulitis) and cellulite. Auxilium has reported positive top-line data from a Phase IIa frozen shoulder study and expects to initiate a new clinical trial in the second half of 2013. BioSpecifics is currently managing the clinical development of XIAFLEX for the treatment of human and canine lipomas, which are both in Phase II clinical trials, with top-line data from both trials expected in the second half of 2013. For more information, please visit www.biospecifics.com.
SOURCE BioSpecifics Technologies Corp.
RELATED LINKS
http://www.biospecifics.com
Source: www.prnewswire.com
Recommended for You
http://wikiste.altervista.org/index.php?title=The_Benefits_Of_Natural_Slimming_Pills
http://uwgeek.com/index.php?do=/blog/6147/effective-guidance-before-you-use-any-diet-pills/
http://shangrilawiki.u21global.com/corpwiki/index.php/The_Benefits_Of_Safe_Slimming_Products
http://saryse.dmusic.net/journal/1846080
http://seedlingsites.com/blogs/985/902/are-you-looking-for-some-answers
No comments:
Post a Comment